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ABSTRACT Alkaline phosphatase is an enzyme with a typical / hydrolase fold. The conformational stability of the human
placental alkaline phosphatase was examined with the chemical denaturant urea. The red shifts of fluorescence spectra show a
complex unfolding process involving multiple equilibrium intermediates indicating differential stability of the subdomains of the
enzyme. None of these unfolding intermediates were observed in the presence of 83 mM NaCl, indicating the importance of ionic
interactions in the stabilization of the unfolding intermediates. Guanidinium chloride, on the other hand, could stabilize one of the
unfolding intermediates, which is not a salt effect. Some of the unfolding intermediates were also observed in circular dichroism
spectroscopy, which clearly indicates steady loss of helical structure during unfolding, but very little change was observed for the
 strand content until the late stage of the unfolding process. The enzyme does not lose its phosphate-binding ability after
substantial tertiary structure changes, suggesting that the substrate-binding region is more resistant to chemical denaturant than
the other structural domains. Global analysis of the fluorescence spectral change demonstrated the following folding-unfolding
process of the enzyme: N7 I17 I27 I37 I47 I57 D. These discrete intermediates are stable at urea concentrations of 2.6,
4.1, 4.7, 5.5, 6.6, and 7.7 M, respectively. These intermediates are further characterized by acrylamide and/or potassium iodide
quenching of the intrinsic fluorescence of the enzyme and by the hydrophobic probes, 1-anilinonaphthalene-8-sulfonic acid and
4,4-dianilino-1,1-binaphthyl-5,5-disulfonic acid. The stepwise unfolding process was interpreted by the folding energy landscape
in terms of the unique structure of the enzyme. The rigid central -strand domain is surrounded by the peripheral -helical and coil
structures, which are marginally stable toward a chemical denaturant.
INTRODUCTION
Alkaline phosphatase (orthophosphoric monoester phospho-
hydrolase (alkaline optimum), EC 3.1.3.1) belongs to the
/ hydrolase fold family (Ollis et al., 1992). This is one of
the most versatile and widespread protein folds known and
represents a typical example of tertiary structure adopted by
various enzymes during divergent evolution (Nardini and
Dijkstra, 1999). Human alkaline phosphatase isoenzymes
have attracted much interest because of their clinical impli-
cations (Fishman, 1990; McComb et al., 1979; Moss, 1992;
Van Hoof and De Broe, 1994). Alkaline phosphatase from
placenta is characteristic for its stability compared with the
other types of mammalian isoenzymes (Fishman, 1990;
McComb et al., 1979). The thermostable properties of the
placental-type alkaline phosphatase versus the thermolabile
properties of the liver-bone-kidney-type isoenzyme had
been used as a clinical diagnostic tool to attempt to differ-
entiate between these isoenzymes (PetitClerc, 1976). The
structural basis for this differential conformational stability
is unclear. More recently, the crystal structure of human
placental alkaline phosphatase became available (Le Du et
al., 2001) and provided a very good model to examine the
molecular basis for the conformational stability of the placental
alkaline phosphatase. This model may provide valuable infor-
mation about the stabilization of a protein molecule in general.
Alkaline phosphatase from Escherichia coli is quite
unique in that the enzyme undergoes continued slow struc-
tural annealing long after the return of enzyme activity
(Subramaniam et al., 1995). We have characterized the
chemical stability of the placental alkaline phosphatase in
GdnHCl in which a stable unfolding intermediate was iden-
tified (Hung and Chang, 1998). To further characterize the
unfolding intermediate of the placental enzyme, we exam-
ined the urea-induced unfolding process. More significant
results were obtained in the present study because more
intermediates were identified.
MATERIALS AND METHODS
Materials
Partially purified human placental alkaline phosphatase (type XVII) and
4-nitrophenyl phosphate were purchased from Sigma-Aldrich (St. Louis,
MO). Concanavalin A-sepharose and Q-sepharose were purchased from
Amersham Pharmacia Biotech (Uppsala, Sweden). Urea and guanidinium
chloride (GdnHCl) were purchased from E. Merck (Darmstadt, Germany).
Acrylamide and potassium iodide (KI) were purchased from Baker (Phil-
lipsburg, NJ). 1-anilinonaphthalene-8-sulfonic acid (ANS) and 4,4-diani-
lino-1,1-binaphthyl-5,5-disulfonic acid (bis-ANS) were purchased from
Molecular Probes (Eugene, OR).
Enzyme preparation
The partially purified enzyme from Sigma-Aldrich was further purified
according to the published procedure by passing through a concanavalin-A
affinity column, followed by a Q-sepharose column (Chang et al., 1992).
The purified enzyme was subjected to sodium dodecyl sulfate-polyacryl-
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amide gel electrophoresis to examine the purity. A single protein band
corresponding to molecular weight of 60 kDa was observed in all cases.
An absorption coefficient of 115  103 M1 cm1 at 280 nm was used for
protein concentration determination. A molecular weight of 115,000 for the
dimeric enzyme was used for calculation of enzyme concentration
(Sakiyama et al., 1979).
Enzyme assay
The assay mixture contained 100 mM NaHCO3-Na2CO3 buffer (pH 9.8),
10 mM MgCl2, 10 mM 4-nitrophenyl phosphate, and an appropriate
amount of enzyme in a total volume of 1 ml. The hydrolyzed product,
4-nitrophenolate anion, was continuously monitored at 30°C with a Lamb-
da-3B spectrophotometer (Perkin-Elmer, Foster City, CA). The increase of
absorbance at 410 nm was always colinear with time. An absorption
coefficient of 18.3  103 M1 cm1 for the 4-nitrophenolate was used for
the calculation of product concentration (Dawson et al., 1986).
Enzyme unfolding
In the chemical unfolding experiments, the enzyme was incubated with
various concentrations of urea in Tris-acetate buffer (0.1 M, pH 7.5) at
30°C for 24 h. The process of enzyme unfolding was monitored by
assaying the initial rate of the residual enzyme activity, the fluorescence
spectrum, and the circular dichroism (CD) change. In the enzyme activity
assays, control experiments were performed simultaneously with the same
amount of denaturant added into the control cuvette where the enzyme was
not preincubated with the denaturant; e.g., if the enzyme was denatured in
3 M urea, then the enzyme activity was assayed in the presence of 3 M
urea. Residual enzyme activity (Et/Eo) was plotted versus denaturant con-
centration, in which Eo and Et are the enzyme activity in the control and
experimental cuvettes, respectively.
For monitoring the refolding process, the enzyme denatured with 8 M
urea was diluted with Tris-acetate buffer (0.1 M, pH 7.5) to lower urea
concentration and the fluorescence spectrum taken after overnight incuba-
tion at room temperature (25°C).
Analysis of the unfolding curves of the unfolding process followed the
procedure of Pace (1986) or Morjana et al. (1993), assuming a two-state or
a three-state unfolding mechanism, respectively (see later section for more
complex unfolding mechanisms).
Spectrofluorimetric analysis
Fluorescence spectra of the enzyme were monitored with a Perkin-Elmer
LS-50B luminescence spectrometer at 30°C, and all spectra were corrected
for the buffer absorption. The Raman spectrum of water was also corrected.
The excitation wavelength was set at 280 or 295 nm, and the fluorescence
emission spectra were scanned from 300 to 400 nm. The maximal peak of
the fluorescence spectrum and the change of fluorescence intensity at 360
nm were used in monitoring the unfolding processes of the enzyme.
Spectropolarimetric analysis
The secondary structure of the enzyme was analyzed by monitoring the CD
spectrum of the protein at 25°C in a Jasco J-810 spectropolarimeter at 205 to
245 nm under constant N2 flush. A quartz cuvette with a 1-mm light path was
used. For direct comparison, all enzyme solutions were adjusted to the same
protein concentration (0.15 mg/ml). The absorption spectrum of the buffer or
buffer plus urea solution was also recorded and was subtracted from the
protein spectrum. All spectra were accumulated over seven repeated scans.
The secondary structure of the enzyme after equilibrium urea unfolding
was estimated by CONTIN, SELCON, and CDSSTR methods with an
expanded reference set (Sreerama and Woody, 2000).
Fluorescence quenching experiments
The details of the enzyme conformation were analyzed with quenching
experiments. Quenching titrations with either acrylamide or KI were per-
formed at 30°C by sequentially added aliquots of the concentrated
quencher stock solution (6 M) to the enzyme solution. Sodium thiosulfate
(0.1 mM) was added to the KI stock solution to prevent I3
 formation. The
excitation wavelength was set at 295 nm, and the fluorescence emission
spectra were scanned from 300 to 400 nm. The integration area among 330
and 360 nm were used for data analysis.
The inner filter effect due to acrylamide absorption was corrected
according to the method of Calhoun et al. (1983)
Fcorr Fobs10 expAex Aem2  (1)
in which Fcorr and Fobs are the corrected and observed fluorescence,
respectively; Aex and Aem are the acrylamide absorptions at the excitation
and emission wavelengths, respectively.
The fluorescence quenching data in the presence in acrylamide or KI were
analyzed by fitting to the Stern-Volmer equation (Eftink and Ghiron, 1981):
Fo/F 1 Ksv Q (2)
in which Fo and F are the fluorescence intensities in the absence or
presence of the quencher, respectively. Ksv is the Stern-Volmer quenching
constant, and [Q] is the quencher concentration.
A double-quenching experiment was also performed to further explore
the protein dynamics. The enzyme was denatured to various degrees by
preincubating the enzyme with different concentrations of urea as stated in
the previous section. An appropriate concentration of KI was added into the
enzyme solution before titrating with acrylamide. The double-quenching
data were calculated by fitting the data according to Somogyi et al. (1985):
F1,2
Fo


1 K1eacrylamide K2KI


1 K1iacrylamide
  (3)
in which Fo is the original protein intrinsic fluorescence intensity and F1,2 is
fluorescence intensity in the presence of both acrylamide and KI. , , and 
represent the fraction of exposed (external), buried (internal), and nonquench-
able fluorophors, respectively. Collisional quenching constants, K1e and K1i,
are characterized for the exposed and the buried fluorophors for the nonselec-
tive quencher, respectively; K2 is characterized for the selective quencher KI,
which is ionic in character and can only quench the exposed fluorophors.
ANS and bis-ANS binding measurement
The excitation wavelengths were set at 370 and 395 nm for ANS and
bis-ANS, respectively, and we rechecked the extinction coefficient of ANS
and bis-ANS. The inner filter effects were corrected by using extinction
coefficients of 5620 M1 cm1 at 370 nm for ANS or 17,100 M1 cm1
at 395 nm for bis-ANS. The emission spectra were scanned between 400
and 600 nm upon the respective excitation. All measurements were cor-
rected for the background intensity of the buffer. The appropriate dilution
factors due to sequential addition of ANS or bis-ANS were also corrected.
For urea unfolding experiments, the concentrations of ANS and bis-
ANS were fixed at 40 and 4.0 M, respectively, and the fluorescence
emission spectra were integrated between 420 and 560 nm upon excitation
at 370 nm and 395 nm, respectively.
For ANS or bis-ANS titration experiments, ANS or bis-ANS stock
solution was sequentially added to the assay mixture and the final concen-
tration of ANS or bis-ANS was 41.3 or 8.3 M, and the fluorescence
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emission intensities at 515 or 500 nm were observed upon excitation at 370
and 395 nm, respectively. The data were analyzed according to a hyper-
bolic binding behavior.
F
FmaxKd
L Kd
(4)
where F is the fluorescence intensity change, [L] is the concentration of
ANS or bis-ANS. The value of Kd indicates the binding affinity of ANS or
bis-ANS for the enzyme, and Fmax is the fluorescence emission maxi-
mum for the maximal number ligand (ANS or bis-ANS) binding.
Molecular weight determination by sucrose-
density gradient ultracentrifugation
Sucrose solutions were prepared with buffers containing the respective
concentration of urea. A total of 12-ml linear sucrose gradient (5 to20%)
in a centrifuge tube was formed with a Haake-Buchler Auto Densi-Flow
IIC gradient former. Placental alkaline phosphatase after equilibrium de-
naturation with different concentrations of urea was layered on the top of
the tube and centrifuged at 6500  g (SW 41 Ti rotor) for 19 h at 25°C in
a Beckman L8–70 ultracentrifuge. The centrifuged solution was fraction-
ated into 30 fractions with the same auto-flow apparatus and assayed for
enzyme activity and protein concentration. Because all sucrose gradients
contained a constant urea concentration, after fractionation each tube will
have the same amount of urea in that particular experiment. In a separate
tube, bovine serum albumin (molecular weight 67,000) and -galactosi-
dase (molecular weight 116,000) were used as molecular weight markers
for the monomeric and dimeric enzymes, respectively.
Quantitative analysis for more complex
unfolding-refolding process
The equations that describe the dependence of an observed structural signal
thermodynamic parameters for a seven-state unfolding model shown in
Scheme 1 has been derived
N ¢O¡
K1
I1 ¢O¡
K2
I2 ¢O¡
K3
I3 ¢O¡
K4
I4 ¢O¡
K5
I5 ¢O¡
K6
D
Scheme 1
in which N and D are the native and denatured states, respectively. I1
through I5 are the various unfolding intermediates. K1 through K6 are the
dissociation constants of the corresponding steps. The detailed derivation
of the equation for a seven-state folding process is given elsewhere,
assuming linear free energy changes theory (Santoro and Bolen, 1988).
According to this established theory each unfolding step has the following
relationship of the standard free energy changes:
Gi
o Gi miD (5)
in which Gi is the free energy change of each step, m represents the
dependence of the G on denaturant concentration [D]. In terms of
equilibrium constants, the following relationships hold.
Ki exp	Gio	 miD
RT  (6)
in which R is gas constant and T is the absolute temperature in Kelvin. The
overall equation that describes a complex folding-unfolding system like
that shown in Scheme 1 is shown in Eq. 7.
yobs

YN YI1 exp 	G1o	 m1D
RT   YI2 exp 	G1
o	 m1D G2
o	 m2D

RT 
 YI3 exp 	G1o	 m1D G2o	 m2D G3o	 m3D
RT 
 YI4 exp 	G1o	 m1D G2o	 m2D G3o	 m3D G4o	 m4D
RT 
 YI5 exp 	G1o	 m1D G2o	 m2D G3o	 m3D G4o	 m4D G5o	 m5D
RT 
 YD exp 	G1o	 m1D G2o	 m2D G3o	 m3D G4o	 m4D G5o	 m5D G6o	 m6D
RT 
	

1 exp 	G1o	 m1D
RT   exp 	G1
o	 m1D G2
o	 m2D

RT 
 exp 	G1o	 m1D G2o	 m2D G3o	 m3D
RT 
 exp 	G1o	 m1D G2o	 m2D G3o	 m3D G4o	 m4D
RT 
 exp 	G1o	 m1D G2o	 m2D G3o	 m3D G4o	 m4D G5o	 m5D
RT 
 exp 	G1o	 m1D G2o	 m2D G3o	 m3D G4o	 m4D G5o	 m5D G6o	 m6D
RT 
	
(7)
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in which Yi is the yobs value of the folding intermediate at the corresponding
plateau region.
For a six-state unfolding model, deleting the last term from denominator
and numerator can derive a similar equation. The same procedure applies
to other equilibrium models. All fitting works were performed on Macin-
tosh G4/500 microcomputer with the Sigma plot 5.0 program.
RESULTS
Multiphasic unfolding of human placental alkaline
phosphatase induced by urea
Fluorescence methods are sensitive in monitoring unfolding
transitions of proteins (Eftink, 1994). When monitored by
fluorescence emission spectrum shifting, human placental
alkaline phosphatase showed multiple intermediate states
during the urea-induced unfolding process (Fig. 1 A). In this
process, the fluorescence wavelength gradually shifted from
327 to 357 nm upon excitation at 280 nm, which excites all
aromatic amino acid residues. The increase of fluorescence
intensity, however, did not reach a plateau even at urea
concentration of 9.5 M, indicating the existence of residual
structures from the placental enzyme at this high concen-
tration of urea (Fig. 1 C).
The unfolding of placental enzyme by urea was concen-
tration dependent at extremely low protein concentrations.
The unfolding curves were almost identical for protein
concentrations between 12.9 and 64.8 g/ml (Fig. 1 A).
Lower protein concentrations down to 3.9 g/ml caused the
enzyme to become more sensitive to urea. Significant dif-
ferences of the red shifting of the curve was observed at a
protein concentration of 3.9 g/ml (Fig. 1 A), but less
change for the fluorescence intensity was observed for
protein concentrations ranging from 3.9 to 64.8 g/ml (Fig.
1 C). Placental alkaline phosphatase is a homodimeric en-
zyme. Dissociation will be sensitive to protein concentra-
tion. If the enzyme did dissociate into two monomers at the
3.9 g/ml protein concentration, the unfolding behavior of
the monomer would still be multiphasic, as shown by open
squares in Fig. 1 A.
The multiphasic unfolding phenomena were analyzed by
computer fitting of the original data to a seven-state or a
six-state unfolding model. The data from 12.9 and 64.8
g/ml were combined in the global analysis for a seven-
state model. The fitted residuals (Fig. 1 B) showed good
distribution around the zero line, indicating an acceptable
model. However, it should be mentioned that there are a
total of 19 parameters to be fitted. Due to the complexity of
the fitting equation and the limited data points, some of the
fitted parameters (e.g., G3 and m3) have very large fitting
errors. We are thus reluctant to report these calculated
thermodynamic parameters. On the other hand, the urea
concentrations that caused one-half transition of each step
([urea]0.5), calculated from Gi/mi, are quite reasonable as
judged visually. The [urea]0.5 levels corresponding to the N
7 I1, I1 7 I2, I2 7 I3, I3 7 I4, I4 7 I5, and I5 7 D
processes are 2.6, 4.1, 4.7, 5.5, 6.6, and 7.7 M, respectively.
Among these, the [urea]0.5 value of 4.7 M for the I2 7 I3
step has large fitting errors because of the very small plateau
region around 4.5 M urea concentration. The data of 3.9
g/ml were best described by a six-state model with
[urea]0.5 at 2.6, 4.0, 5.4, 5.6, and 7.1 M, for the N 7 I1, I1
7 I2, I2 7 I3, I3 7 I4, and I4 7 D, respectively. Among
these, the 5.4 M value for the I2 7 I3 is also questionable
but may be equivalent to the same transition at [urea]0.5 
4.7 M, as observed at higher protein concentrations. The
only missing one at lower protein concentrations thus could
be the I47 I5 process at [urea]0.5  6.6 M, which might be
related to the dissociation/reassociation process (see below).
The unfolding process monitored by fluorescence spectra
was completely reversible at urea concentrations up to 8 M.
When the 8 M urea-denatured enzyme was diluted up to
10-fold to various degrees, fluorescence spectra obtained
were identical with those of the unfolding enzymes at that
urea concentration (solid circles in Fig. 2 A). These results
suggest that the same folding-unfolding pathway was fol-
lowed.
Quite different results were obtained when the same
enzyme solution was excited with 295 nm of UV light,
which registers only the tryptophanyl fluorescence of the
enzyme. The fluorescence wavelength shift was monopha-
sic, but the fluorescence intensity change was multiphasic
(Fig. 3). The noncoincidence of different structural probes
strongly indicates the existence of intermediates in the fold-
ing-unfolding process. The unfolding curves measured by
the fluorescence wavelength shift and the fluorescence in-
tensity were analyzed by two-state and five-state unfolding
processes, respectively. The urea concentration that causes
half of the fluorescence wavelength shift, [urea]0.5, was at
4.5 M. The [urea]0.5 values for the fluorescence intensity
change were estimated to be 1.7, 5.2, 6.3, and 7.5 M. Some
of the reliable thermodynamic parameters for these unfold-
ing processes are summarized in Table 1.
Intermediate form during the urea-induced
unfolding of human placental alkaline
phosphatase can be stabilized by guanidinium
chloride but not by NaCl
We have demonstrated a GdnHCl-induced biphasic unfold-
ing process of the enzyme and also ruled out a salt effect on
that biphasic phenomenon (Fig. 2 A, inset graph) (Hung and
Chang, 1998). The urea-induced multiphasic unfolding phe-
nomenon of placental alkaline phosphatase changed to
monophasic by adding NaCl (83 mM) into the enzyme
solutions during urea denaturation (Fig. 2 A, open squares).
In the presence of salt, the unfolding curve measured by the
fluorescence intensity change shifted to the left compared
with the unfolding curve of urea only (Fig. 2 B, open
squares). This indicates that addition of NaCl destabilizes
the enzyme. We then checked the effect of GdnHCl on the
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urea unfolding. Biphasic unfolding of the placental enzyme
was observed by addition of GdnHCl (83 mM) during urea
unfolding (Fig. 2 A, open triangles). The unfolding curve for
FIGURE 1 Multiphasic unfolding of human placental alkaline phospha-
tase induced by urea. Human placental alkaline phosphatase (‚, 64.8
g/ml; E, 12.9 g/ml; , 3.88 g/ml) in Tris-acetate buffer (0.1 M, pH
7.5) was unfolded with various concentrations of urea at 30°C for 24 h. The
enzyme was excited at 280 nm and the fluorescence spectrum was recorded
at 30°C. (A) Fluorescence emission maxima of the enzyme versus urea
concentration. The symbols are experimental results, and the lines through
these symbols are the computer fitted results according to a seven-state
unfolding model for combined data from protein concentrations at 64.8 and
12.9 g/ml, or according to a six-state unfolding model for protein con-
centration at 3.88 g/ml. (B) Fitting residues for the seven-state unfolding
model (combined data of protein concentrations at 64.8 and 12.9 g/ml).
Number of different repeating experiments (N  7). (C) Fluorescence
intensity (
  360 nm) of the denatured enzymes versus urea concentra-
tion. The same symbols are used as in A.
FIGURE 2 Effect of salt and guanidinium chloride on the fluorescence
spectra of human placental alkaline phosphatase in the urea unfolding
process. Human placental alkaline phosphatase (12.9 g/ml) in Tris-
acetate buffer (0.1 M, pH 7.5) was denatured with various concentrations
of urea in the absence (E) and in the presence of 83 mM NaCl () or 83
mM GdnHCl (‚). The excitation wavelength was set at 280 nm, and the
fluorescence spectra were monitored between 300 and 400 nm. (A and B)
Fluorescence wavelength shifting and the relative fluorescence intensities
change at 360 nm, respectively. For comparison, the enzyme denatured by
various concentrations of guanidinium chloride is shown in inset graphs of
A and B. All the data were fitted according to two-state ( in A and all
curves in B), three-state (‚ and inset curves in A), or seven-state unfolding
mechanism (E in A). The reversibility of the unfolding process was
demonstrated by diluting the 8 M urea-denatured enzyme to lower urea
concentrations with the enzyme concentration kept constant at 12.9 g/ml
(F in A) (N  2).
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the fluorescence wavelength shift induced by urea plus
GdnHCl was similar to that of the GdnHCl alone (Hung and
Chang, 1998). Because 83 mM GdnHCl itself did not in-
duce any unfolding of the enzyme (Hung and Chang, 1998),
these results indicated that GdnHCl, but not NaCl, could
help to entrap an unfolding intermediate and stabilize it
during the unfolding process induced by urea. In the pres-
ence of GdnHCl, the [urea]0.5 were estimated to be 3.9 and
5.2 M for the N7 Ii and Ii7 Ii1 processes, respectively.
For the fluorescence intensity, data was fitted to a two-state
transition, and the corresponding value of [urea]0.5 was 6.3 M.
The unfolding curves for the fluorescence wavelength
shift and fluorescence intensity changes in the presence of
NaCl were fitted to the two-state transition separately. The
corresponding values for [urea]0.5 were 4.4 M for fluores-
cence wavelength shift, and 6.5 M for fluorescence intensity
change, respectively, in the presence of NaCl.
Urea-induced multiphasic unfolding of human
placental alkaline phosphatase detected
by CD spectroscopy
Fig. 4 shows the equilibrium unfolding of human placental
alkaline phosphatase monitored by CD at 222 nm. The
relative CD signal change for the enzyme was best de-
scribed by a four-state unfolding model during urea unfold-
ing with three equilibrium [urea]0.5 at 0.4, 3.5, and 7.4 M,
respectively (Fig. 4 A). Multiple intermediates seemed to be
observed by adding 83 mM NaCl, however, all of these
intermediates were destabilized by salt (Fig. 4 B), similar to
those results on fluorescence (Fig. 2 A). One of these
intermediates was stabilized by guanidinium chloride (83
mM) (Fig. 4 C), which was similar to the results observed
from the fluorescence wavelength change (Fig. 2 A).
GdnHCl itself induced a monophasic denaturation curve
(Fig. 4 D). It is clear that multiple unfolding intermediates
were also seen from the secondary structure change of the
placental enzyme during the urea-induced unfolding
process.
We then tried to correlate the CD signal to secondary
structural changes of the enzyme. Prediction of secondary
structure from the CD data varied considerably between
different programs used. On the basis of known crystal
structure of placental enzyme, we found that the program
provided by Jasco was unreliable in protein secondary struc-
ture estimation. The recently published method (Sreerama
and Woody, 2000) gave reasonably good estimations and
was used in the present report. The helical contents of the
unfolded enzyme decreased biphasically and monophasi-
cally, respectively, in the urea and GdnHCl denaturation
(Fig. 5). The failure of helical contents to reveal more
intermediates may be due to the insensitivity of the predic-
tion programs. NaCl or GdnHCl can stabilize some of the
helical structure in the urea-induced unfolding process (Fig.
5 A). The  strand structure, on the other hand, did not vary
much until the very late stage of the denaturation process
(data not shown).
Effect of urea on the kinetic parameters of
human placental alkaline phosphatase
Human placental alkaline phosphatase was activated by low
concentrations of urea but was denatured at high urea con-
centrations. The enzyme activity was 1.2-fold higher than
the native enzyme at 0.4 to 0.5 M urea. The activation and
unfolding was a time-dependent process, indicating slow
conformational changes at the active site of the protein. It
FIGURE 3 Tryptophan fluorescence in human placental alkaline phos-
phatase during urea unfolding process. Human placental alkaline phospha-
tase (12.9 g/ml) in Tris-acetate buffer (0.1 M, pH 7.5) was denatured with
various concentrations of urea at 30°C for 24 h. The enzyme was excited
at 295 nm, and the fluorescence spectrum was recorded at 30°C. (A)
Fluorescence emission wavelength versus urea concentration. (B) Fluores-
cence intensity (
  360 nm) versus urea concentration. The symbols are
the experimental data and the lines are the computer fitting results accord-
ing to a two- (A) or a five-state (B) model.
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took at least a 24-h incubation for the enzyme activity
change to reach equilibrium. The unfolding curve for en-
zyme activity change followed a three-state unfolding
model (Fig. 6 A, open circles).
The inactivated enzyme activity was completely revers-
ible up to 6 M urea (Fig. 6 A, closed circles). Higher urea
concentrations caused partial reversibility of the enzyme
activity. The change of kcat values versus urea concentration
showed a biphasic pattern (Fig. 6 B), similar to that shown
in Fig. 6 A. On the other hand, the Michaelis constant for the
substrate, 4-nitrophenyl phosphate was not changed at all in
the urea concentrations tested (Fig. 6 C). These results
indicate a rigid structure of the enzyme at the substrate-
binding region.
Exploration of the structural dynamics of human
placental alkaline phosphatase during urea
unfolding by fluorescence-quenching
experiments
Human placental alkaline phosphatase contains four trypto-
phan residues, and each tryptophan residue was character-
ized by its unique microenvironmental properties. Depend-
ing on their location in the protein matrix, they may be
exposed to the solvent to various degrees. Quenching ex-
periments were performed to detect the fluctuations of tryp-
tophan residues in the placental alkaline phosphatase during
the unfolding process. Acrylamide, a nonionic and a non-
selective quencher, was able to penetrate the protein matrix
and to quench the fluorescence of both exposed and buried
tryptophan residues in proteins (Calhoun et al., 1983). In
contrast, KI, a selective ionic quencher, could only quench
the fluorescence of exposed tryptophan residues located at
or near the protein surface (Lehrer, 1971).
More recently, Dobryszycki et al. (1999) have demon-
strated that high concentrations of acrylamide induces time-
dependent unfolding of rabbit muscle aldolase, which in-
volves several intermediate states. In our case, the
acrylamide concentration used was only up to 0.4 M, and
the fluorescence quenching was measured immediately after
adding the quencher. The use of acrylamide for analysis of
the microenvironment of enzyme fluorophors induced by
conformational changes of the enzyme should be safe (La-
kowicz, 1999).
The data for the acrylamide and KI quenching of the
native and denatured placental alkaline phosphatase were
calculated according to the Stern-Volmer equation (Eq. 2).
The slopes of the fitted lines, which represent the Stern-
Volmer collisional quenching constants (Ksv) ascended with
an increase of urea concentration indicating exposure of
tryptophan residues during protein unfolding process (Fig.
7). Because of the red shifting of the fluorescence spectrum
during enzyme unfolding, the quenching data were based on
the integrated area between 330 and 360 nm. The Ksv values
for KI quenching were smaller than those for acrylamide.
The Ksv values of native and 8 M urea-denatured enzymes
were 3.47 0.06 M1 and 7.74 0.05 M1 for acrylamide
quenching, and 0.69  0.01 M1 and 1.90  0.24 M1 for
KI quenching, respectively. The Ksv values versus urea
concentration for acrylamide and KI quenching were shown
in Fig. 7 C.
A double-quenching experiment was performed to further
characterize the solvent-exposed and solvent-masked flu-
orophors during unfolding of the placental enzyme, and the
TABLE 1 Comparison of the conformational stability of the various unfolding intermediates of human placental alkaline
phosphatase detected by different structural probes in urea unfolding process
Physical probes [Urea]0.5, (M)

max (Ex 280 nm) ([protein]  12.9 g/ml) 2.6 4.1 4.7 5.5 6.6 7.7

max (Ex 280 nm) ([protein]  3.88 g/ml) 2.6 4.0 5.4 5.6 7.1

max (Ex 280 nm)* (in 83 mM NaCl) 4.4 (12  2.8)
†

max (Ex 280 nm) (in 83 mM GdnHCl) 3.9 (13  1.8) 5.2 (17  13)

max (Ex 295 nm) 4.5 (18  2.7)
F360 (Ex 280 nm) 8.5 (2.8  0.2)
F360 (Ex 280 nm) (in 83 mM NaCl) 6.5 (3.0  0.5)
F360 (Ex 280 nm) (in 83 mM GdnHCl) 6.3 (4.8  0.9)
F360 (Ex 295 nm) 1.7 (2.0  0.7) 5.2 (8.0  2.4) 6.3 (98  1.3) 7.5 (10  3.2)
CD 0.4 (5.7  0.9) 3.5 (5.3  1.2) 7.4 (7.2  1.1)
CD (in 83 mM GdnHCl) 4.1 (12  5.1) 7.3 (14  1.8)
Enzyme activity 3.9 (6.9  2.8) 6.5 (1.8  0.7)
ANS binding 3.1 (4.4  1.7) 6.1 (6.3  2.0)
Bis-ANS binding‡ 0.8 (3.5  1.0) 4.3 (1.7  0.7)
Bis-ANS binding§ 1.0 (1.4  0.6) 6.0 (8.4  1.0)
*Starting from this row, the protein concentration was 12.9 g/ml.
†The numbers in parentheses are the free energy changes (G in kcal/mol) calculated by fitting the results to the corresponding equations.
‡From area integration data.
§From maximum fluorescence emission wavelength data.
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experimental details are described in the Materials and
Methods section. The double-quenching data were analyzed
according to Eq. 3 (Somogyi et al., 1985). The primary plots
gave a reasonable good fit (data not shown). The final fitting
results are shown in Fig. 8. It can be seen that collisional
quenching constants of the internal (K1i) fluorophors for
FIGURE 4 Changes of molecular ellipticity of human placental alkaline
phosphatase in the urea unfolding process. Human placental alkaline phos-
phatase (0.15 mg/ml) in Tris-acetate buffer (0.1 M, pH 7.5) was denatured
with various concentrations of urea in the absence (A) and in the presence
of 83 mM NaCl (B) or 83 mM GdnHCl (C). Molecular ellipticity at 222 nm
FIGURE 5 Helical contents of the human placental alkaline phosphatase
during the urea unfolding process. The data shown in Fig. 4 were used in
secondary structure estimation. Helical contents of the enzyme denatured
with urea at various levels were estimated by CD spectra using the
programs CONTIN, SELCON, and CDSSTR (Sreerama et al., 2000). (A)
Human placental alkaline phosphatase denatured with urea in the absence
(E) and in the presence of 83 mM NaCl () or 83 mM GdnHCl (‚). (B)
The same amount of enzyme denatured in GdnHCl.
was used to monitor the enzyme structural changes. (D) Enzyme denatured
by various concentrations of guanidinium chloride. The curves in A and B
were fitted to a four-state or a five-state unfolding mechanism, respec-
tively; whereas the data of C and D were fitted to a three-state or a
two-state unfolding mechanism, respectively (N  2).
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acrylamide increased but not the external (K1e) and colli-
sional quenching constant for KI (K2) with the denatured
enzyme (Fig. 8 B). The fractions of exposed () and buried
() tryptophan residues in the native placental enzyme were
0.3 and 0.6, respectively, which changed to 0.8 and
0.2 for the 7 M urea-denatured enzyme. There were
10% non-quenchable () fluorophors in the native en-
zyme. The quenching parameters,  and  versus concen-
tration of urea seemed to follow a monophasic curve (Fig. 8
A). However, due to the limited data points and large errors,
no further quantitative analysis was performed.
Detection of unfolding intermediates of human
placental alkaline phosphatase by ANS and bis-
ANS binding during urea-induced denaturation
ANS and bis-ANS are fluorescent compounds that have the
ability to bind with hydrophobic areas on a protein mole-
cule. Thus, they are excellent probes to detect unfolding
intermediates, which usually involve exposure of internal
hydrophobic areas.
ANS and bis-ANS exerted opposite binding behavior
with the placental alkaline phosphatase. The ANS fluores-
cence increased at increasing urea concentration, indicating
that ANS preferred binding to the denatured enzyme rather
than to the native enzyme (Fig. 9 A). The maximal emission
wavelength at 515 nm of ANS did not change upon urea
unfolding. In contrast, bis-ANS fluorescence decreased at
increasing urea concentration, and the fluorescence wave-
length changed biphasically from 498 to 518 nm, reaching
a plateau at 503 nm between 2 to 5 M urea and then
undergoing another change above 6 M urea (Fig. 9 B). The
integrated fluorescence area also showed a biphasic process.
The unfolding curves measured by ANS and bis-ANS
fluorescence were fitted to a three-state unfolding model to
estimate the corresponding thermodynamic parameters (Ta-
ble 1). The [urea]0.5 values, corresponding to the N7 Ii and
Ii 7 Ii1 processes monitored by the ANS binding, were
estimated to be 3.1 and 6.1 M, respectively. For the bis-
ANS fluorescence intensity change, the corresponding val-
ues were 0.8 and 4.3 M, respectively. For the red shifting of
bis-ANS fluorescence, the corresponding values of [urea]0.5
were 1.0 and 6.0 M, respectively (Table 1).
Titration of the native- or denatured-enzyme with ANS
and bis-ANS gave series of hyperbolic curves (data not
shown). The titration curves were calculated according to a
saturation phenomenon (Eq. 4) to estimate the apparent
dissociation constants (Kd) between enzymes and ANS/bis-
ANS (Table 2). The results clearly indicated that ANS
molecules have stronger binding affinity to the denatured
enzyme than to the native enzyme because the Kd values for
the enzyme-ANS complex progressively decreased as the
enzyme was gradually denatured. The dissociation con-
stants for the ANS bound to the native enzyme and to the 8
M urea-denatured enzyme were 165.4 and 111.7 M, re-
FIGURE 6 Effect of urea on the enzymatic activity of human pla-
cental alkaline phosphatase. (A) The enzyme (12.9 g/ml in Tris-
acetate buffer, 0.1 M, pH 7.5) was denatured with various concentra-
tions of urea at 30°C for 24 h. The enzyme activity was then assayed at
30°C without (F) or with (E) the corresponding concentration of urea
in the assay mixture. For those without addition of urea in the reaction
mixture, the final urea concentration was diluted 10-fold in the assay
mixture. (B and C), kcat and Km (4-nitrophenyl phosphate) versus urea
concentration plots. The kinetic parameters of the partially denatured
enzyme were determined at various concentrations of the substrate with
the corresponding concentration of urea added in the assay mixture
(N  2).
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spectively. On the other hand, bis-ANS molecules bound
more weakly to the denatured enzyme than the native en-
zyme, and the Kd values were 5.4 0.9 M and 16.0 4.0
M for the native- and 8-M urea-denatured enzymes, re-
spectively.
Quaternary structure of human placental alkaline
phosphatase during urea denaturation
Human placental alkaline phosphatase is a homodimeric
protein. Our previous experimental results clearly indicated
that GdnHCl-induced denaturation of the enzyme is bipha-
sic in nature (Hung and Chang, 1998). The biphasic phe-
nomenon is a simultaneous dissociation-denaturation pro-
cess. Because the dissociation and denaturation occurred
simultaneously, it was not possible to clearly distinguish
between these two processes.
The molecular weight of the equilibrium-denatured en-
zyme in various concentrations of urea was examined by
sucrose-density gradient ultracentrifugation under denatur-
ing conditions. The enzyme existed as dimers in the absence
of denaturant (Fig. 10 A) and dissociated during urea dena-
turation (Fig. 10). The dimeric enzyme was 80% dissoci-
ated at urea concentration of 6 M, where the fluorescence or
CD signals have not reached a maximum (Figs. 1–4). The
results cannot differentiate dissociation and denaturation as
separate steps during urea denaturation.
DISCUSSION
The detailed mechanism that directs the primary structure of
a polypeptide chain to fold into the correct biologically
active enzyme is a challenging question and has raised
much discussion (cf. Aurora et al., 1997; Beasley and
Hecht, 1997; Brockwell et al., 2000; Dill, 1997, 1999;
Fedorov and Baldwin, 1997; Ruddon and Bedows, 1997;
Tsai et al., 1999). Several models for the mechanism of
protein folding have been proposed. The simple sequential
model postulates a unique folding pathway with defined and
sequential intermediates. More recently, the model of en-
sembles and funnel landscapes has attracted much attention
(Baldwin, 1995; Dill, 1999; Dill and Chan, 1997; Tsai et al.,
1999). On one hand, the folding of small proteins may be
rapid with no detectable intermediates, conforming to a
FIGURE 7 Quenching of the intrinsic fluorescence of human placental
alkaline phosphatase by acrylamide or KI. Human placental alkaline phos-
phatase (12.9 g/ml) in Tris-acetate buffer (0.1 M, pH 7.5) was denatured
with 0 (E), 3.0 (F), 4.5 (), 5.0 (f), 6.0 (‚), 7.0 (Œ), or 8.0 M () urea
at 30°C for 24 h. The denatured enzymes were then mixed with increasing
amounts of acrylamide (A) or KI (B) and the fluorescence spectra of the
enzyme were monitored. The integration area of the fluorescence emission
spectrum between 330 and 360 nm was calculated. The excitation wave-
length was set at 295 nm. The dilution and inner filter effects were
corrected. (C) Stern-Volmer collisional quenching constants (Ksv) versus
urea concentration plot. The quenching constants (E, from acrylamide
quenching; F, from KI quenching) were obtained from the linear regres-
sion analysis of the data shown in A and B according to the Stern-Volmer
equation (Eq. 2). The curves in C were the fitted results according to a
two-state or three-state unfolding mechanism (N  4).
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smooth funnel energy landscape (cf. Huang and Oas, 1995;
Schindler et al., 1995; Sosnick et al., 1994). Large proteins
or proteins that consist of several structural domains, on the
other hand, may show multiple intermediates during the
folding process reflected in a rugged funnel landscape (for
reviews, see Bai and Englander, 1996; Fink et al., 1998;
Jaenicke, 1996; Jennings and Wright, 1993; Kim and Bald-
win, 1990; Privalov, 1996; Sugawara et al., 1991).
Folding and assembly of alkaline phosphatase in vitro
and in vivo have been intensively investigated due to dif-
ferential stability of this enzyme from various sources
(Akiyama and Ito, 1993; Cioni et al., 1989; Hoylaerts and
Milla´n, 1991; Mersol et al., 1993; Miggiano et al., 1987;
FIGURE 8 Variations of the fraction of accessible groups and quenching
constants of the urea-denatured human placental alkaline phosphatase
toward the nonselective or the selective quenchers accessed by double
quenching of the intrinsic fluorescence of the enzyme by acrylamide and
KI. Human placental alkaline phosphatase (12.9 g/ml) in Tris-acetate
buffer (0.1 M, pH 7.5) was denatured with 0 to 8 M urea at 30°C for 24 h.
KI (0–0.3 M) was added into the assay mixture. The denatured enzymes
containing various concentrations of KI were then mixed with increasing
amounts of acrylamide. The emission spectrum areas among 330 to 360 nm
were calculated. The excitation wavelength was set at 295 nm. The dilution
and inner filter effects were corrected. The data were computer analyzed
according to Eq. 3. (A) , , and , which represent the external, internal,
and nonquenchable fluorophors of total fraction fluorophors, were used in
analyzing the unfolding process. (B) Variations of external (K1e) and
internal (K1i) quenching constants for acrylamide and quenching constant
for KI (K2) in urea denaturation (N  2).
FIGURE 9 Binding of ANS and bis-ANS to the urea-denatured human
placental alkaline phosphatase. Human placental alkaline phosphatase
(12.9 g/ml) in Tris-acetate buffer (0.1 M, pH 7.5) was denatured with
various concentrations of urea at 30°C for 24 h and the fluorescence
emissions were measured after ANS or bis-ANS addition. (A) ANS fluo-
rescence of the urea-denatured alkaline phosphatase. The excitation wave-
length was set at 370 nm, and the integrated area of the fluorescence
emission spectrum between 420 and 560 nm was calculated. The final
concentration of ANS was 40.0 M. (B) bis-ANS fluorescence of urea-
denatured alkaline phosphatase. The excitation wavelength was set at 395
nm. The final concentration of bis-ANS was 4.0 M. These data were
fitted to three-state unfolding model (N  3). (E) Integrated emission
fluorescence area; (F) fluorescence wavelength shift.
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Sarkar and Ghosh, 1996; Subramaniam et al., 1995). We
have focused here on characterizing the equilibrium unfold-
ing in chemical denaturants to delineate the thermodynamic
stability of the placental alkaline phosphatase. In this paper,
we show that the reversible unfolding/refolding of human
placental alkaline phosphatase in urea definitely involves
multiple equilibrium unfolding/folding intermediate states,
which implies differential conformational stability among
FIGURE 10 Sucrose-density gradient ultracentrifugation of the urea-denatured human placental alkaline phosphatase. The enzyme was denatured with
various concentrations of urea in Tris-acetate buffer (0.1 M, pH 7.5) and ultracentrifuged in a 5 to 20% sucrose-density gradient at 6500  g for 19 h
to separate the dimeric and monomeric enzyme molecules. (A to D) Urea concentrations of 0, 2.0, 4.0, and 6.0 M, respectively. , Bovine serum albumin
(2 mg, molecular weight 67,000); F, -galactosidase (0.1 mg, molecular weight 116,000); , placental alkaline phosphatase (63 g) (N  2).
TABLE 2 Binding of ANS or bis-ANS to the urea-unfolding human placental alkaline phosphatase*
Urea concentration
(M)
ANS Bis-ANS
Fmax Kd (M) Fmax Kd (M)
0 577.0  81.9 165.4  29.8 916.3  51.3 5.4  0.9
1.0 –† – 615.8  61.0 8.9  1.5
2.0 760.5  106.5 153.3  25.9 – –
3.0 792.4  101.4 144.1  22.5 561.4  59.5 10.6  1.8
4.5 843.5  122.3 136.5  23.5 547.3  62.4 13.1  2.2
5.0 875.6  129.6 132.4  24.2 539.7  61.0 15.3  2.4
6.0 893.4  79.5 132.2  14.4 519.3  61.3 14.7  2.4
7.0 903.3  69.6 118.9  11.5 516.9  102.4 16.8  4.0
8.0 949.9  70.3 111.7  10.5 486.8  93.5 16.0  4.0
*The Fmax and Kd values for the ANS and bis-ANS binding were calculated according to Eq. 4 (N  3).
†Not detected.
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the subdomains of the enzyme. The non-coincidence of the
unfolding curves for enzyme intrinsic fluorescence (Figs.
1–3), CD spectroscopy (Fig. 4), the quenching experiments
for accessibility of fluorophors (Fig. 8), the ANS and bis-
ANS binding to the hydrophobic region of the enzyme (Fig.
9), together with enzymatic activity changes (Fig. 6) all
demonstrate that there are indeed multiple unfolding/refold-
ing intermediates entrapped during urea unfolding process.
At least six transitions were detected by various structural
probes. The midpoints of these transitions were 0.4 to 2.6
M, 3.1 to 4.1 M, 4.3 to 5.4 M, 5.2 to 5.6 M, 6.0 to 6.6 M,
and 7.1 to 8.5 M urea, respectively, in the minimal unfold-
ing sequence shown in Scheme 1.
Human placental alkaline phosphatase is a dimeric en-
zyme and has four tryptophan residues in each monomer.
The overall structure of placental alkaline phosphatase is
similar to the E. coli enzyme (Kim and Wyckoff, 1991;
Murphy et al., 1995) and has a basic three-layer ()
sandwich architecture with a central 10-stranded -sheet
flanked by 15 helices and another three-stranded -sheet,
along with coils and loops (Fig. 11). The placental enzyme
is characterized by a crown domain, an additional N-termi-
nal helix, and another metal-binding domain (Le Du et al.,
2001). The active site region is located at the upper part of
the central -sheet, containing the Zn1-Zn2-Mg metal trip-
let that is important for maintaining the rigidity of the
protein interior as well as for catalysis (Stec et al., 2000;
Hung and Chang, 2001). Each monomer of the enzyme can
be divided into several domains. The core 10-stranded
-sheet constitutes the rigid central sheet domain II. The
surrounding helical and coiled structures are divided into
two parts. The N-terminal part constitutes domain I, which
also contains the minor three-stranded -sheet as well as the
crown domain and the N-terminal helix characteristic of the
placental enzyme. This domain is extensively involved in
the subunit association in the dimeric enzyme. The C-
terminal region constitutes domain III. Correlation of these
structures to conformational stability is revealed by sensi-
tivity of the enzyme to chemical denaturants.
Tryptophanyl fluorescence or phosphorescence has been
demonstrated to be excellent structural probe for E. coli
alkaline phosphatase (Cioni et al., 1989; Mersol et al., 1991,
1993; Strambini, 1987; Subramaniam et al., 1995; Sun et
al., 1997). The four Trp in the placental enzyme are 100%
conserved in mammals but not in bacteria. Trp-168 and
Trp-237 are located in the coil and helix regions, respec-
tively, of the C-peripheral domain, whereas Trp-248 is
located at the side of the central -sheet region. Trp-12 is
located at the large N-terminal helix. The even distributions
of the four Trp in placental alkaline phosphatase make Trp
fluorescence an excellent probe for monitoring the struc-
tural changes of the enzyme (Fig. 11). Analysis of the
accessibility of these Trp by the SwissPDB Viewer (Guex
and Peitsch, 1997) indicates the following accessibility or-
der: Trp-12  Trp-248  Trp-168  Trp-237. The Km of
the substrate was not changed at urea concentrations up to 8
M (Fig. 6 C). This is consistent with the polypeptide chain
flexibility information shown in Fig. 11 B. The active center
is located at a rigid region of the molecule.
The importance of metal ions and the phosphate ion in the
structural stability of E. coli alkaline phosphatase had been
examined by Janeway et al. (1993). Placental alkaline phos-
phatase has an extra structural metal ion in addition to the
Zn1-Zn2-Mg1 catalytic triad. We have demonstrated previ-
ously that the placental alkaline phosphatase is stabilized in
GdnHCl-denaturation in the presence of 1 mM phosphate
and 10 mMMgCl2. The [GdnHCl]0.5 increased from 1.66 M
for the Mg-free enzyme to 2.95 M for the Mg-phosphate
containing enzyme (Hung and Chang, 2001). Removing the
tightly bound zinc ions from the enzyme by exhaustive
dialysis with nitriloacetic acid resulted in an enzymatically
inactive enzyme form, which had a different conformation
as detected by fluorescence quenching (Hung and Chang,
2001). The multiple conformations detected in the enzyme
with various metal contents strongly suggest the involve-
ment of metal ions in stabilization of some parts of the
structural integrity.
The quaternary structure of the enzyme was quite stable.
The urea unfolding of the enzyme was a simultaneous
dissociation-unfolding process. The x-ray structure of pla-
cental alkaline phosphatase explains the extra-stability of
the quaternary structure of the placental enzyme. There are
extensively entangled structures at the monomer-monomer
interface. The interactions between two monomers are re-
markable, e.g., C-terminal loop at the bottom and the large
crown domain on the top of each monomer wind around
each other; the long N-terminal helix on the bottom also
extends deeply into another monomer. Substitution of a
single amino acid of the bacteria alkaline phosphatase at the
interface region sacrifices not only the integrity of the
assembled dimer but also the stability of the monomer fold
(Martin et al., 1999). This situation is even more pro-
nounced in the mammalian placental enzyme, which has
two large domains at the interface region. For this reason, it
is conceivable that folded monomers cannot be separated,
even at a high concentration of chemical denaturants. Mo-
lecular weight determination by sucrose density gradient
ultracentrifugation indicated that the quaternary structure of
the enzyme is quite stable in urea, and the fluorescence
signal is insensitive to protein concentration in the enzyme
amounts used in most of the experiments (12.9 g/ml).
Folded monomeric species do not exist at any equilibrium.
In this extreme case, the energetics can be treated in man-
ners similar to that for a monomeric protein unfolding
process (Cai and Schirch, 1996; Neet and Timm, 1994),
albeit multiple unfolding intermediates might be involved in
multidomain proteins. The second transition of enzyme
activity change, which has a midpoint at 6.5 M urea, might
be attributed to the dissociation of the subunits. This con-
clusion is supported by the fitting results shown in Fig. 1 A.
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At low enzyme concentrations, the missing transition thus
may be assigned to the dissociation step, which is the
second to last step in the unfolding pathway at higher
protein concentrations (Table 1).
The properties of ANS and bis-ANS binding to the en-
zyme during urea unfolding are interesting because they
show opposite results. As shown in Fig. 9 A, the ANS
molecule prefers to bind to the denatured enzyme rather
than to the native enzyme. However, the behavior of the
bis-ANS molecule was just the opposite, preferring to bind
with the native enzyme rather than to the denatured enzyme
(Fig. 9 B). These observations may be attributed to the
amphipathic nature of the ANS-type dyes (Lakowicz,
1999). The different binding behaviors of ANS and bis-
ANS suggest that they might have entrapped different un-
folding intermediates. The molecular weight of bis-ANS is
2-fold larger than ANS, and the two halves of bis-ANS
molecule are perpendicular to each other (Arighi et al.,
1998), which might cause some different steric effects and
result in the opposite fluorescence change between ANS
and bis-ANS.
In the present study, we provide conclusive evidence that
demonstrates the multiple equilibrium unfolding/refolding
intermediate states of the placental alkaline phosphatase.
Because the unfolding and refolding follow the same path-
way, the unfolding of placental alkaline phosphatase in urea
seems to follow a sequential rather than a nonsequential
pathway (Sa´nchez del Pino and Fersht, 1997). However, it
is very difficult to assume the rate-limiting step of the
sequential unfolding process from the free energy informa-
tion, which vary substantially among different biophysical
techniques. More recently, Dignam et al. (2001) also de-
tected multiple unfolding intermediates of the glycyl-tRNA
synthetase by the emission fluorescence spectral shift and
places our work into a useful perspective. The novel part in
the present case is that an unusually high number of inter-
mediates were entrapped in vitro during urea unfolding
process of human placental alkaline phosphatase. However,
it should be pointed out that because relatively low and
physiological concentrations of salt do cancel out many of
the intermediates shown in Fig. 1 A, all these intermediates
might not be involved in the normal in vivo folding envi-
ronment of the enzyme inside the cell. With these caveats in
mind, we try to interpret our data in terms of tertiary
structure and energy landscape of the enzyme.
Because we have identified several discrete unfolding
intermediates, the final landscape of the native enzyme
should have a ragged surface. The peripheral domains are
unfolded in the early stages of the unfolding process with
FIGURE 11 Structural features of human placental alkaline phospha-
tase. (A) The structure of placental alkaline phosphatase (pdb code:
1ew2) clearly indicates the basic  folding pattern, designated as
domains I, II, and III, respectively. The active site region is located at
the top of the central 10-stranded -sheet, highlighted with the bound
phosphate (purple) and the Zn1-Zn2-Mg3 metal triplet region (large
balls in gray and violet, respectively). The four Trp residues (W12,
W168, W237, and W248) are presented in green ball-and-stick. Com-
paring with the bacterial alkaline phosphatase, the structural features of
the placental enzyme include a crown domain on top (purple), a
N-terminal helix (green), and an additional metal binding domain
(blue), which contributed additional components to the  main
structure. The additional metal ion (Mg2) is shown as a yellow ball.
(B) The structural flexibility of the enzyme is shown as a variable worm
of the polypeptide chain. The rigid structure of the central -sheets is
shown as a thinner worm in blue. The more flexible peripheral regions are
shown in red. Only one of the subunits is shown. This figure was generated
with MOLSCRIPT (Kraulis, 1991) and rendered with Raster3D program
(Merrit and Murphy, 1994).
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formation of some intermediates of nearly equal free en-
ergy. On the other hand, the central core structures are more
stable and are the first parts to find their way in the land-
scape searching in the folding process. As demonstrated in
Fig. 1 C, the fluorescence intensity of the enzyme at urea
concentrations up to 9.5 M still did not reach a plateau, so
the denatured state should not be regarded as a completely
unfolded random coil. The folding pathway is hypothesized
as follows: fusion of microdomain or building blocks forms
the partially folded monomers, I5. Association of two par-
tially folded monomers results in the formation of partially
folded dimers, I4. The formation of intermediate form I3 is
followed by central domain annealing, which transforms to
I2 and I1 states by incorporation of peripheral domains I
and/or II, and then finally reaches the functional dimeric
enzyme. In these intermediate macrostates, the enzyme mol-
ecules that have large degrees of freedom can have many
conformations (microstates). In other words, any interme-
diate state does not mean a single trap in the energy funnel
but represents an average over many microscopic confor-
mations. This conclusion is corroborated by the fact that the
active site of E. coli alkaline phosphatase can be reconsti-
tuted by a number of pathways (Sarkar and Ghosh, 1996).
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